(Q53276513)

English

Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production.

scientific article published on 10 January 2011

Statements

Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit